CorMedix Inc. (CRMD)
NASDAQ: CRMD · IEX Real-Time Price · USD
4.650
-0.010 (-0.21%)
At close: Jul 19, 2024, 12:00 AM
4.670
+0.020 (0.43%)
Pre-market: Jul 22, 2024, 9:05 AM EDT
CorMedix Employees
As of December 31, 2023, CorMedix had 83 total employees, including 82 full-time and 1 part-time employees. The number of employees increased by 42 or 102.44% compared to the previous year.
Employees
83
Change (1Y)
42
Growth (1Y)
102.44%
Revenue / Employee
n/a
Profits / Employee
-$605,279
Market Cap
255.56M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
MultiPlan | 2,800 |
AirSculpt Technologies | 381 |
Codexis | 174 |
Nektar Therapeutics | 137 |
Monte Rosa Therapeutics | 133 |
Profound Medical | 131 |
Inovio Pharmaceuticals | 122 |
Sanara MedTech | 108 |
CRMD News
- 19 days ago - CorMedix Inc. Announces Outpatient Availability of DefenCath - GlobeNewsWire
- 6 weeks ago - CorMedix Inc. Announces CMS Grants Pass-Through Status to Defencath - GlobeNewsWire
- 7 weeks ago - CorMedix Inc. Announces Commercial Agreement With Top Tier Dialysis Provider - GlobeNewsWire
- 2 months ago - CorMedix Inc. to Participate in Two Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024 - GlobeNewsWire
- 3 months ago - CorMedix Inc. Announces CMS Grants TDAPA to DefenCath - GlobeNewsWire
- 3 months ago - CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin) - GlobeNewsWire